How to Screen FTSE 100 Stocks Like a Hedge Fund Manager

There is a persistent myth in retail investing that professional stock pickers possess some form of superior intuition — an ability to look at a company and "feel" whether it is a good investment. In reality, the most successful professional investors — and particularly the systematic and quantitative funds that dominate institutional money management — use repeatable, data-driven processes to identify investment opportunities.

The most powerful and proven of these processes is factor investing: selecting stocks based on documented characteristics that have historically generated excess returns above the market. And the first step in any factor-based investment process is the stock screen.

In this guide, we walk you through the exact framework that quantitative hedge funds use to screen equity markets — and show you how to replicate it using Fintiq's free Fundamental Screener, applied to the FTSE 100.

The Myth vs Reality of Hedge Fund Stock Selection

When most retail investors imagine a hedge fund manager selecting stocks, they picture someone doing exhaustive bottom-up research: reading every annual report, meeting management teams, building complex financial models, and forming deep qualitative views on competitive dynamics.

Some hedge funds do work this way. But many of the world's largest and most successful quantitative funds — Two Sigma, AQR Capital, D.E. Shaw, Renaissance Technologies — rely far more heavily on systematic, data-driven factor screens than on individual company analysis. They process financial data across thousands of companies simultaneously, identify stocks that score well on proven factors, and construct portfolios based on systematic signals rather than individual analyst conviction.

Renaissance Technologies' Medallion Fund — arguably the most successful investment fund in history, returning approximately 66% per year before fees from 1988 to 2018 — was almost entirely systematic. It did not rely on fundamental analysis in the traditional sense. It relied on identifying and exploiting statistical patterns in data.

While individual retail investors cannot replicate the full sophistication of a quant hedge fund, they can absolutely apply the same underlying principles — screening for stocks with superior characteristics across proven factors — and expect to generate meaningful improvements in their investment outcomes as a result.

The Academic Foundation: Factor Investing

Factor investing has deep academic roots. The foundation was laid by economists Eugene Fama and Kenneth French in their landmark 1992 paper that extended the traditional Capital Asset Pricing Model (CAPM) to include two additional factors beyond market exposure:

• Value factor: cheap stocks (low price relative to fundamentals) have historically outperformed expensive stocks over long periods
• Size factor: small companies have historically outperformed large companies over long periods

Subsequent research identified additional factors that explain excess returns:

• Quality factor: profitable, financially stable, well-managed companies outperform
• Momentum factor: stocks that have performed well recently tend to continue performing well in the medium term (3–12 months)
• Low volatility factor: less volatile stocks have historically delivered higher risk-adjusted returns than more volatile stocks

These factors have been tested across decades of data, across multiple markets including the UK, and have proven remarkably persistent. They are the basis of the fastest-growing segment of institutional asset management — factor-based or "smart beta" strategies — which now manage trillions of dollars globally.

For an individual investor screening the FTSE 100 with Fintiq, these four factors — Quality, Value, Momentum and Growth — provide the framework for a systematic, evidence-based approach to stock selection.

The Four Factors to Screen For

Factor 1: Quality

Quality is perhaps the most important factor for long-term equity investors. High-quality businesses — those with durable competitive advantages, strong management, and robust financial health — tend to outperform not just in absolute terms but especially during market downturns, when lower-quality businesses face disproportionate pressure.

When screening for quality in the FTSE 100, look for:

• Return on Equity above 15%: ideally sustained over 3–5 years, not just a single year that might be distorted by a one-off event
• Consistent operating margins: not wildly fluctuating year to year, which suggests genuine pricing power and cost control rather than fortuitous conditions
• Conservative balance sheet: Debt-to-Equity below 1.0 for most non-financial companies
• High free cash flow conversion: FCF consistently above 70% of net income — meaning the company's reported earnings are genuinely reflected in cash generation
• Clean accounting: no unusual one-off items that inflate reported profits, no aggressive revenue recognition, no history of earnings restatements

FTSE 100 quality examples: AstraZeneca (exceptional ROE, strong FCF, dominant pharmaceutical pipeline), Diageo (pricing power in spirits, consistent margins, high ROE), RELX (recurring subscription revenues, expanding margins, high FCF), Experian (global market leadership in credit data, high ROE), Halma (consistent organic growth, high-quality niched safety businesses).

Factor 2: Value

The value factor captures the insight that investors systematically overpay for popular, well-publicised companies and underpay for unfashionable ones. Value investors exploit this by buying businesses at prices below their intrinsic worth.

Value metrics to screen for:

• P/E Ratio below sector average: a company trading at a significant discount to its sector peers may be mispriced
• Price-to-Book below 1.5: for mature, asset-based businesses — though this is less relevant for asset-light businesses where book value understates economic value
• EV/EBITDA below 10x: Enterprise Value to EBITDA is a cleaner valuation metric than P/E for cross-company comparisons as it removes the effect of different capital structures
• Dividend yield above sector average: a high dividend yield can indicate undervaluation, provided the dividend is covered by earnings

Factor 3: Momentum

The momentum anomaly — one of the most robustly documented phenomena in financial markets — shows that stocks that have outperformed the market over the past 6–12 months tend to continue outperforming over the next 3–12 months. This runs counter to the intuition that recent winners should "mean revert." Yet the empirical evidence across global markets, including the UK, is remarkably consistent.

For the FTSE 100 screen, momentum can be incorporated as:

• 6-month price return above the median FTSE 100 stock: the stock is in the upper half of recent performers
• 12-month price return above the FTSE 100 index return: outperforming the index over the past year
• Positive earnings revisions: analysts are revising their earnings estimates upward, reflecting improving business conditions

A critical caveat: momentum is a medium-term phenomenon. It reverses sharply during market crashes and sector rotations. Momentum signals are best used as a secondary filter (to choose between otherwise comparable quality-value candidates) rather than as a primary screen.

Factor 4: Growth

Growth stocks — companies that are growing revenues and earnings faster than the market — tend to outperform over long periods when purchased at reasonable valuations. The growth factor captures this dynamic.

Growth metrics to screen for:

• Revenue growth above 5% annually: the company is genuinely expanding its market presence
• Accelerating margins: as the business scales, it is becoming more profitable per pound of revenue — a sign of operating leverage
• Rising EPS trend: earnings per share growing consistently over 3–5 years
• Positive analyst estimate revisions: forward earnings estimates are being upgraded, suggesting the market is becoming more optimistic about future prospects

The Quality + Value Sweet Spot

The single most powerful combination of factors — the one that has generated the most consistent long-term outperformance across academic research and real-world investing — is Quality + Value. High-quality businesses trading at below-average valuations.

This is exactly what Warren Buffett has described as his investment philosophy: "It is far better to buy a wonderful company at a fair price than a fair company at a wonderful price." A wonderful company is a quality business. A fair price is a valuation metric that is not stretched. The combination is the holy grail.

In the FTSE 100, this intersection is relatively rare at any given time — most high-quality businesses trade at premium valuations because the market recognises their quality. But periodic sector rotations, market corrections, or individual company-specific selloffs can bring high-quality businesses to attractive valuations. The systematic screen finds them automatically and immediately.

Setting Up the Screen in Fintiq: Step by Step

This screen — taking under two minutes to set up — immediately narrows the 100 companies in the FTSE 100 down to a shortlist of typically 5–15 companies that score well across all three primary factors. The Quality Score sort then ranks them so the most compelling candidates appear first.

Interpreting Fintiq's Quality Score

The Quality Score is Fintiq's proprietary composite rating, calculated on a scale of 0–100 for every stock. It combines multiple financial dimensions into a single comparable ranking:

• Financial Health: balance sheet strength, debt management, interest coverage
• Profitability: ROE, operating margins, FCF margins, ROIC (Return on Invested Capital)
• Growth Momentum: revenue growth trend, earnings growth trend, margin trajectory
• Relative Valuation: how the stock's valuation metrics compare to its sector peers and its own historical averages

How to interpret the Quality Score:

Important: use the Quality Score as a ranking tool, not as a precise absolute measure. The difference between a score of 76 and 79 is not meaningful. The difference between 85 and 55 is highly meaningful. Sort your screen results by Quality Score and focus your attention on the top-ranked candidates.

Red Flags: What to Filter Out

Equally important to knowing what to look for is knowing what to avoid. The following characteristics should prompt immediate removal from your watchlist — or at minimum, extremely careful scrutiny before proceeding:

• Declining revenues for two or more consecutive years. A single year of revenue decline may be cyclical or pandemic-related. Two consecutive years suggests structural deterioration — the business is losing competitive ground.
• Negative free cash flow. A company consistently burning cash needs external financing to survive. This is a fundamental problem, not an accounting quirk.
• Rapidly increasing debt levels. If a company is borrowing heavily not to fund investment (which can be productive) but to fund operations or dividends, it is a sign of underlying financial weakness.
• High and rising share dilution. When shares outstanding increase significantly year over year, existing shareholders are being diluted — meaning each share is worth a smaller piece of the company even if the overall business is growing.
• Inconsistent or declining margins. Margin compression over multiple years suggests the company is losing pricing power or facing rising cost pressures that it cannot pass on to customers.
• Structural industry disruption without clear response. Print media, fossil fuel retail, physical entertainment retail — industries facing structural change require extraordinary conviction about the specific company's ability to navigate the disruption before investment.

A Case Study: Applying the Screen

To illustrate how this works in practice, here is a hypothetical walkthrough of what a FTSE 100 Quality + Value + Growth screen might surface in a typical market environment:

After applying the filters described above — ROE above 15%, D/E below 1.0, positive FCF, P/E below 20, revenue growth above 5% — the screen might return 8–12 companies. Sorted by Quality Score, the top results might include:

• A global data analytics company with consistently high ROE, growing subscription revenues, and a P/E that has dipped below its 5-year average following a sector rotation
• A specialist healthcare business with strong FCF conversion, minimal debt, and a management team with a long track record of consistent organic growth
• A consumer goods company with exceptional brand portfolio, global distribution, and historically high margins — trading at a discount to its US peers despite comparable business quality

The specifics depend on when you run the screen. Market conditions change, valuations shift, and different companies will emerge at different times. The point of the systematic screen is to find these opportunities immediately, without requiring you to manually check every FTSE 100 company.

What to Do After the Screen

The screen creates a shortlist. The shortlist is not a buy list. After the screen produces your top 10–15 candidates, the qualitative work begins:

1. Read the most recent annual report (or at minimum the CEO's letter, the business overview, and the risk section). Understand what the company actually does and what it believes are the key risks to its business.
2. Assess the competitive moat. Why does this company earn a consistently high ROE? What stops a competitor from eating into its margins? Is that advantage durable or temporary?
3. Check the management track record. How long has the current CEO been in post? What have they said about capital allocation? Have they consistently delivered on stated targets?
4. Look at analyst coverage. What do the 5–10 analysts who cover this company professionally think? Are estimates rising or falling? What are the key concerns they raise?
5. Run a DCF valuation in Fintiq. Cross-reference the screen valuation with an intrinsic value estimate. Is the market price justified by the company's cash flows?
6. Make a sizing decision. If the qualitative research confirms the screen signal, determine what position size is appropriate given your portfolio's existing exposure and your conviction level.

Common Screening Mistakes — And How to Avoid Them

1. Screening for cheap P/E alone. The single most dangerous screen is simply "lowest P/E." This almost guarantees loading your portfolio with value traps — businesses that look cheap because they are in genuine trouble.
2. Ignoring sector context. A 25% ROE is average in an asset-light technology business but exceptional in grocery retail. Always compare metrics within sectors, not across them indiscriminately.
3. Over-trusting single-year data. A company with ROE of 28% last year but 8% the year before and 11% the year before that does not have sustainably high returns. Look for consistency across at least three years.
4. Setting too many tight filters simultaneously. If you apply eight strict criteria, you may well end up with zero results — not because there are no good companies, but because no single company scores in the top quartile on every dimension simultaneously. Start with three or four criteria and tighten incrementally.
5. Treating screen results as buy signals. The screen narrows your search universe. It does not tell you the right price to pay, the right time to buy, or whether qualitative factors support the quantitative signal. Screens are a starting point, not an endpoint.
6. Neglecting to re-run screens regularly. Markets move. A company that didn't pass your screen three months ago might be a compelling opportunity today after a 20% pullback. Build the habit of running your standard screens monthly.

With discipline and consistency, this systematic approach to FTSE 100 stock selection can significantly improve the quality of your investment shortlist — and ultimately the quality of your portfolio. You are not guaranteed to outperform the market every year. But by systematically selecting companies that score well on proven factors, you shift the probability distribution of outcomes meaningfully in your favour over long periods.